Innovative cancer treatment approach yields promising results in pediatric patients

Researchers have developed a functional precision medicine approach that targets cancer by combining genetic testing with a new way to test individual drugs on tumor samples.

FDA pushes cancer drug developers to include overall survival data more frequently

For years, the FDA has allowed progression-free survival to serve as both a primary and surrogate endpoint to support speedy new cancer drug approvals. But

November 1, 2023

Alumis aims for this year’s third-largest biotech IPO as it readies for Phase 3

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 25, 2024

Medicare drug price negotiation’s day in court

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in

February 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.